18G HydroMARK Marker Overview
Authorized Mammotome HydroMARK supplier. The 18G HydroMARK marker (PN 4010-02-18-T3) is a titanium breast biopsy site marker that uses Mammotome exclusive hydrogel technology. Because the hydrogel carrier stays visible for the long term, clinicians can locate the biopsy site with confidence. In addition, the marker shows a unique anechoic appearance under ultrasound, which supports later localization.
This Coil 3 variant is a fine 18 gauge marker packaged 10 units per case. It is visible under ultrasound, mammography, and MRI, so it fits multimodality follow-up pathways. Furthermore, the titanium and hydrogel construction is indicated for axillary lymph nodes and breast tissue where local approval allows. As a result, one marker family can serve many breast care plans.
Need pricing? Get a quote with lead times within one business day.
18G HydroMARK Marker Features
The 18G HydroMARK marker pairs a titanium element with an exclusive hydrogel carrier. Therefore it delivers durable ultrasound visibility while remaining readable on mammography and MRI.
Mammotome hydrogel technology gives this marker long-term ultrasound visibility. Because the hydrogel appears anechoic, it presents a distinct target for the localization preference of the care team.
Visibility can extend up to 12 months, even after neoadjuvant chemotherapy. In addition, the marker remains easy to see under MRI during a T2 sequence, so follow-up imaging stays consistent.
The titanium element makes the marker distinguishable under mammography. As a result, radiologists can confirm placement quickly after deployment.
This marker is indicated for axillary lymph nodes and breast tissue where local approval applies. Furthermore, applicators support ultrasound and MR-guided biopsy workflows, so the same marker family covers several procedures.
See how the 18G HydroMARK marker compares with a generic metal clip marker.
The Coil 3 titanium marker deploys through fine 18 gauge access. Because each case holds 10 units, stocking and scheduling stay simple for busy breast centers.
Full Specifications
Every specification below comes directly from Mammotome source documentation for the HydroMARK marker family and part number 4010-02-18-T3.
| Product | Mammotome HydroMARK marker |
| Part number | 4010-02-18-T3 |
| Gauge | 18G |
| Configuration | Coil 3, titanium |
| Units per case | 10 |
| Marker material | Titanium |
| Carrier | Hydrogel |
| Marker family | HydroMARK |
| Technology | Exclusive hydrogel |
| Ultrasound appearance | Unique anechoic |
| Ultrasound duration | Up to 12 months |
| Post-neoadjuvant chemo | Visible up to 12 months |
| Mammography | Visible |
| MRI | Visible on T2 sequence |
| Applicators | Ultrasound and MR-guided biopsies |
| Guidance modalities | Ultrasound, MRI |
| Indicated sites | Axillary lymph nodes and breast tissue |
| Regional note | Indication may not be approved in all regions |
| Compatible devices | Hologic Celero, BD EleVation |
| Also compatible | Traditional spring-loaded core needle devices |
| Compatibility data | Mammotome ES-000398 |
| Manufacturer | Devicor Medical Products, Inc. |
Clinical Applications
The 18G HydroMARK marker supports a wide range of breast care pathways. Here are common ways clinical teams put it to work.
Deploy the marker during an ultrasound-guided biopsy. Because the hydrogel is anechoic, the site stays visible for later imaging.
Track a biopsy site over time. Ultrasound visibility can last up to 12 months, so surveillance stays reliable.
Keep the target readable after neoadjuvant chemotherapy. As a result, surgical planning remains accurate.
Give the care team a clear target for their localization preference. Therefore intra-operative planning becomes easier.
Mark axillary nodes where local approval allows. The titanium and hydrogel design suits both node and breast tissue.
Confirm the site during MRI. The marker is easy to see during a T2 sequence, which supports multimodality follow-up.
Breast Biopsy Marking Workflow
The 18G HydroMARK marker fits into a clear procedural pathway from deployment to follow-up.
Deploy the marker at the end of the biopsy through a compatible fine 18 gauge access device. Because delivery is straightforward, the workflow stays fast.
Confirm placement under mammography or ultrasound. The titanium element is distinguishable under mammography, and the hydrogel shows a unique anechoic appearance under ultrasound.
Follow the biopsy site over time. Ultrasound visibility can extend up to 12 months, even after neoadjuvant chemotherapy, so tracking stays dependable.
Support the localization preference of the surgical team. As a result, the marker offers a clear target when the care plan moves toward excision.
Image the site again when MRI is needed. The marker remains visible during a T2 sequence, which keeps multimodality follow-up consistent.
Compliance and Quality
Review the regulatory and quality notes below before ordering. They come directly from Mammotome documentation and Medical Outfitters supplier policy.
The product and its indications may not be approved or available in every region. Therefore, confirm local approval with your Mammotome representative and consult the Instructions for Use before clinical use.
The HydroMARK marker family is indicated for axillary lymph nodes and breast tissue where approval applies. In addition, always follow the full Instructions for Use for deployment and imaging guidance.
Devicor, Mammotome, and HydroMARK are registered trademarks of Devicor Medical Products, Inc. This marker is manufactured by Devicor Medical Products, Inc.
Medical Outfitters Inc. is an ISO 13485:2016 certified medical imaging equipment supplier based in Miami, FL. As a result, we manage sourcing, documentation, and fulfillment under a certified quality management system.
Ordering and lead time
Request current pricing, case quantities, and lead time for PN 4010-02-18-T3. Our team confirms availability and shipping details on every order.
Technical support
Need help matching this marker to your biopsy device or imaging workflow? Contact Medical Outfitters for product and compatibility guidance.
Frequently Asked Questions
Common questions about the 18G HydroMARK marker, PN 4010-02-18-T3.
It is made of titanium with an exclusive hydrogel carrier. Because of this design, it stays visible under ultrasound while remaining readable on mammography and MRI.
Ultrasound visibility can last up to 12 months. In addition, the marker remains visible even after neoadjuvant chemotherapy.
Yes. The marker is easy to see under MRI during a T2 sequence, so it supports multimodality follow-up.
This is a fine 18 gauge (18G) marker in the Coil 3 titanium configuration. Therefore it suits fine-needle access workflows.
Each case includes 10 units. As a result, stocking for a busy breast center stays simple.
Mammotome documentation lists compatibility with Hologic Celero, BD EleVation, and traditional spring-loaded core needle devices. Always confirm compatibility in the Instructions for Use.
The HydroMARK family is indicated for axillary lymph nodes and breast tissue where local approval applies. However, indications may not be approved in every region.
You can buy it from Medical Outfitters Inc., an ISO 13485:2016 certified supplier in Miami, FL. Call (305) 885-4045 for pricing, availability, and lead time.
Compatible Equipment
Explore sibling breast biopsy site markers available at Medical Outfitters.
Request a Quote Today
Get in touch with Medical Outfitters today to request your personalized quote and outfit your facility with confidence.
Related Products
Mammotome MammoMARK MMK1001 Bowtie Biopsy Site Identifier, Titanium Collagen Marker, CS10
Mammotome HydroMARK 10G Flexible Side-Deploy Applicator, PN 4010-05-10-T4
Mammotome Elite MEP10 10 ga Probe with Cannula Included, CS5
